Beetham Thomas W.
Insider CIK 1741382 · VRDN Chief Operating Officer · MGTA See Remarks · KNSA EVP & Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics, Inc | M Exercise deriv | 2026-03-03 | 2026-03-04 | 9,409 | — | $0 | 28,227 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | F Tax w/h | 2026-03-03 | 2026-03-04 | 3,138 | $29.32 | $92.0K | 13,271 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise | 2026-03-03 | 2026-03-04 | 9,409 | — | $0 | 16,409 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | F Tax w/h | 2026-03-03 | 2026-03-09 | 3,048 | $30.19 | $92.0K | 13,361 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2026-03-02 | 2026-03-04 | 176,550 | — | $0 | 176,550 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2026-03-02 | 2026-03-04 | 35,300 | — | $0 | 35,300 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2025-03-03 | 2025-03-04 | 37,636 | — | $0 | 37,636 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2025-03-03 | 2025-03-04 | 225,814 | — | $0 | 225,814 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | P Buy | 2024-09-27 | 2024-09-30 | 5,000 | $23.41 | $117.0K | 6,000 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2023-10-30 | 2023-11-01 | 474,400 | — | $0 | 474,400 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award | 2022-11-30 | 2022-12-02 | 3,000 | $0.94 | $2.8K | 19,897 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2022-08-01 | 2022-08-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award | 2022-05-31 | 2022-06-06 | 3,000 | $0.99 | $3.0K | 16,897 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2022-05-17 | 2022-05-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2022-02-15 | 2022-02-17 | 75,000 | — | $0 | 75,000 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | S Sale | 2021-09-16 | 2021-09-20 | 6,103 | $6.73 | $41.1K | 13,897 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award | 2021-09-14 | 2021-09-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2021-06-14 | 2021-06-15 | 200,000 | — | $0 | 200,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-03-20 | 2021-03-23 | 4,287 | — | $0 | 4,287 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-03-20 | 2021-03-23 | 5,855 | — | $0 | 5,855 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-03-16 | 2021-03-18 | 52,611 | — | $0 | 52,611 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-03-16 | 2021-03-18 | 8,769 | — | $0 | 8,769 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion deriv | 2021-02-03 | 2021-02-05 | 300,000 | — | $0 | 114,157 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion | 2021-02-03 | 2021-02-05 | 300,000 | — | $0 | 300,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2021-02-03 | 2021-02-05 | 2,477 | $22.09 | $54.7K | 297,523 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2020-09-10 | 2020-09-14 | 75,000 | — | $0 | 75,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2020-07-01 | 2020-07-02 | 26,734 | $25.32 | $676.9K | 2,855 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2020-07-01 | 2020-07-02 | 2,855 | $25.84 | $73.8K | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2020-06-10 | 2020-06-12 | 13,752 | — | $0 | 112,189 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2020-06-10 | 2020-06-12 | 13,752 | $1.59 | $21.9K | 43,341 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2020-06-10 | 2020-06-12 | 13,752 | $25.07 | $344.8K | 29,589 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2020-04-21 | 2020-04-22 | 955 | $20.44 | $19.5K | 29,589 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2020-04-21 | 2020-04-22 | 1,563 | $19.56 | $30.6K | 30,544 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2020-04-20 | 2020-04-22 | 47,423 | $19.06 | $903.9K | 32,107 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2020-03-13 | 2020-03-17 | 75,000 | — | $0 | 75,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2020-02-14 | 2020-02-19 | 59 | $18.58 | $1.1K | 79,530 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2019-09-17 | 2019-09-19 | 45,000 | — | $0 | 45,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2019-03-04 | 2019-03-06 | 42,000 | — | $0 | 42,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2018-09-20 | 2018-09-24 | 45,000 | — | $0 | 45,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion deriv | 2018-05-29 | 2018-05-29 | 48,172 | — | $0 | 414,157 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion deriv | 2018-05-29 | 2018-05-29 | 6,392 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion deriv | 2018-05-29 | 2018-05-29 | 48,172 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion | 2018-05-29 | 2018-05-29 | 6,392 | — | $0 | 79,589 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | P Buy deriv | 2018-02-09 | 2018-05-29 | 6,392 | $15.64 | $100.0K | 6,392 | SEC↗ |